NOW IN CANADA: HLS Therapeutics Inc. is pleased to announce that Vascepa® (icosapent ethyl [IPE]) is now authorized for sale by Health Canada
If you would like more information about Vascepa®, please fill out the form below.
By clicking here, I agree to allow HLS Therapeutics Inc. to contact me by email regarding its products, programs, news and events. I may update my information, or modify or withdraw my consent, at any time, by contacting HLS Therapeutics Inc.'s Privacy Officer (647-495-9000) at 10 Carlson Court, Suite 410, Etobicoke, Ontario, M9W 6L2, E-mail: email@example.com.
* Required field
10 Carlson Court, Suite 701
Etobicoke, Ontario, M9W 6L2
Vascepa® is a registered trademark of the Amarin group of companies. © 2020 HLS Therapeutics Inc.